Influence of aging and comorbidity in the choice of disease-modifying treatments for multiple sclerosis in the Lazio region

被引：0
|
作者：
Pozzilli, C. [1 ,2 ]
Gasperini, C. [3 ]
Bargagli, A. M. [4 ]
Cascini, S. [4 ]
Buttari, F. [5 ,6 ]
Centonze, D. [5 ,6 ]
Di Folco, M. [1 ]
Francia, A. [1 ]
Galgani, S. [3 ]
Giuliani, M. [2 ]
Colais, P. [4 ]
Mirabella, M. [7 ]
Nociti, V. [7 ,8 ]
Davoli, M. [4 ]
机构：
[1] Univ Roma La Sapienza, Dept Neurol & Psichiatry, Rome, Italy
[2] Univ Roma La Sapienza, Multiple Sclerosis Ctr, S Andrea Hosp, Rome, Italy
[3] AOS Camillo Forlanini, Dept Neurosci, Rome, Italy
[4] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
[5] Tor Vergata Univ & Hosp, MS Clin & Res Ctr, Rome, Italy
[6] IRCCS Ist Neurol Mediterraneo INM Neuromed, Pozzilli, Italy
[7] Catholic Univ, Dept Geriatr Neurosci & Orthoped, Rome, Italy
[8] Fdn Don C Gnocchi, Inst Neurorehabil, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1478
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [1] Update on Disease-Modifying Treatments for Multiple Sclerosis
    Carrithers, Michael D.
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 1938 - 1945
  • [2] Disease-modifying treatments for progressive multiple sclerosis
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1428 - 1436
  • [3] Cancer and multiple sclerosis in the era of disease-modifying treatments
    Lebrun, Christine
    Vermersch, Patrick
    Brassat, David
    Defer, Gilles
    Rumbach, Lucien
    Clavelou, Pierre
    Debouverie, Marc
    de Seze, Jerome
    Wiertlevsky, Sandrine
    Heinzlef, Olivier
    Tourbah, Ayman
    Fromont, Agnes
    Frenay, Marc
    JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1304 - 1311
  • [4] Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis
    Zeydan, Burcu
    Azevedo, Christina J.
    Makhani, Naila
    Cohen, Mikael
    Tutuncu, Melih
    Thouvenot, Eric
    Siva, Aksel
    Okuda, Darin T.
    Kantarci, Orhun H.
    Lebrun-Frenay, Christine
    CNS DRUGS, 2024, 38 (12) : 973 - 983
  • [5] Disease-modifying treatments in children and adolescents with multiple sclerosis
    Eraksoy, M
    Yapici, Z
    Ayta, S
    Akman-Demir, G
    Bilgili, E
    Topcular, B
    Ozcan, H
    JOURNAL OF NEUROLOGY, 2004, 251 : 62 - 63
  • [6] Cancer and multiple sclerosis in the era of disease-modifying treatments
    Christine Lebrun
    Patrick Vermersch
    David Brassat
    Gilles Defer
    Lucien Rumbach
    Pierre Clavelou
    Marc Debouverie
    Jérôme de Seze
    Sandrine Wiertlevsky
    Olivier Heinzlef
    Ayman Tourbah
    Agnes Fromont
    Marc Frenay
    Journal of Neurology, 2011, 258 : 1304 - 1311
  • [7] Established and novel disease-modifying treatments in multiple sclerosis
    Cross, A. H.
    Naismith, R. T.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (04) : 350 - 363
  • [8] Past and Present of Disease-Modifying Treatments in Multiple Sclerosis
    Eraksoy, Mefkure
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 46 - 55
  • [9] Compliance to Multiple Sclerosis Disease-Modifying Therapies: A Population-Based Cohort Study In The Lazio Region, Italy
    Bargagli, Anna Maria
    Agabiti, Nera
    Mayer, Flavia
    Cascini, Silvia
    Colais, Paola
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 354 - 355
  • [10] Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis
    Thompson, Joel P.
    Abdolahi, Amir
    Noyes, Katia
    PHARMACOECONOMICS, 2013, 31 (06) : 455 - 469
12345